Three more children settle Epilim sodium valproate cases

Three more children settle Epilim sodium valproate cases

Sodium valproate, manufactured by Sanofi and sold as Epilim, has been linked to a high risk of serious injury for babies in the womb. File picture

Three more children have settled cases against the HSE linked to their mother taking epilepsy drug Epilim during pregnancy as families call for redress for all affected.

Also on Thursday the Department of Health said it will not publish an interim report from a public inquiry looking at regulation of sodium valproate, sold as Epilim and manufactured by Sanofi.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited